Oscar Health (OSCR) shed 13% on Thursday despite reporting better-than-expected Q2 2026 financials and raising its full-year profit outlook after the health insurer flagged a worse-than-feared membership churn rate for H2.

The New York-based firm, a leading operator in the ACA